Special extraction device for main ingredient collagen II of natural cartilage matrix

Abstract

The invention discloses a special extraction device for main ingredient collagen II of natural cartilage matrix. The special extraction device comprises an incubator, a centrifugal device arranged in the incubator, and a control system used for controlling the temperature in the incubator and the action of the centrifugal device, wherein the centrifugal device comprises a centrifugal machine, a container device installed on the centrifugal machine, a liquid adding system used for adding a reagent into the container device, a filtering and liquid discharging system used for discharging waste liquid in the container device, and a stirring system used for stirring the reagent. The special extraction device for main ingredient collagen II of natural cartilage matrix disclosed by the invention can be used for automatically completing the extraction of the main ingredient collagen II of the natural cartilage matrix, effectively saving the manpower, reducing the production cost and improving the production efficiency.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

This patented technology helps make it easier by automating the process of making artificially made cartilages that replace damaged ones found naturally on bone or other parts of our body's joints. It saves time and money compared with traditional methods like surgery techniques.

Problems solved by technology

This patents discusses methods for treating diseases associated with cartilages such as degenerating knee ligaments (DL), rheumatoid arthritis (RA) and sprains due to severe sports injuries like ski jumpers. Current therapies involve surgery alone, costly procedures involving autologous graft donor organs, and complex implantations requiring prolonged recovery periods. Therefore there exists an urgent technical problem how to develop effective therapeutic agents without these drawbacks while reducing their complexity and expenses involved during manufacturing processes.

Images